Clinical trial
A Study of Pyridostigmine in Postural Tachycardia Syndrome
NCT00409435 · Mayo Clinic, Other · Recruiting
Key facts
| NCT number | NCT00409435 |
|---|---|
| Title | A Study of Pyridostigmine in Postural Tachycardia Syndrome |
| Official title | Double-Blind, Placebo-Controlled Study of Pyridostigmine in Postural Tachycardia Syndrome |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Recruiting |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Postural Tachycardia Syndrome |
| Intervention type | Drug |
| Interventions | pyridostigmine, Placebo |
| Enrollment | 50 |
| Start date | Oct 1, 2006 |
| Primary completion | Feb 1, 2026 |
| Completion | Feb 1, 2026 |
| First posted | Dec 8, 2006 |
| Last update posted | Jul 14, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: